Abstract

Biocatalysis has become recently a promising tool for chemical synthesis. In particular, enzymes as lipases and esterases are often used to resolve racemicmixtureof esters.Weproposeaenantiospecific enzymatic resolution in order to produce enatiopure synthons precursor of pharmaceutical active substances. The process consists in the enantiospecific hydrolysis of a water-soluble racemic mixture of cis-dimethyl 1-acetylpiperidine2,3-dicarboxylate catalyzed by Candida antarctica lipase B. The separation of product in (2R,3S) configuration from unreacted substrate in (2S,3R) configuration is easily obtained by organic phase extraction. This latter form could be used as enantiomerically pure precursor in the (4aS,7aS)-octahydro-1H-pyrrolo[3,4-b]pyridine synthesis, an expensive building block of the antibiotic Moxifloxacin. By the other hand, the hydrolysed form with (2R,3S) configuration could be used for the preparation of neuromediator analogues. Studies concerning hydrolysis and use of immobilized enzyme has been carried out in order to evaluate its industrial application. The enzyme demonstrate high enantiospecificity, concerning the (2R,3S) enantiomer, and regioselectivity, concerning the ester in position 3. The process has been subject for patent application.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.